Although recombinant C5a modestly enhanced cell viability, tumorsphere formation, and matrigel invasion in GBM tumorspheres (TS15-88, TS14-15, and U87), these effects were consistently less pronounced than those elicited by tMSLC-derived CM. The gene discussed is C5AR1; the disease is glioblastoma.